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Abstract
Obesity and type 2 diabetes (T2DM) are characterized by a blunted metabolic
response to insulin, and strongly manifests in skeletal muscle insulin resistance.
The orphan nuclear receptors, Nur77 and NOR1, regulate insulin-stimulated
nutrient metabolism where Nur77 and NOR1 gene expression is increased with
acute aerobic exercise and acute insulin stimulation. Whether Nur77 or NOR1
are associated with the insulin-sensitizing effects of chronic aerobic exercise
training has yet to be elucidated. Fourteen lean healthy controls (LHC), 12
obese (OB), and 10 T2DM individuals (T2DM) underwent hyperinsulinemic-
euglycemic clamps with skeletal muscle biopsies. Muscle was analyzed for
Nur77 and NOR1 gene and protein expression at basal and insulin-stimulated
conditions. Furthermore, a subcohort of 18 participants (OB, n = 12; T2DM,
n = 6) underwent a 12-week aerobic exercise intervention (85% HRmax,
60 min/day, 5 days/week). In response to insulin infusion, LHC increased pro-
tein expression of Nur77 (8.7  3.2-fold) and NOR1 (3.6  1.1-fold), whereas
OB and T2DM remained unaffected. Clamp-derived glucose disposal rates cor-
related with Nur77 (r2 = 0.14) and NOR1 (r2 = 0.12) protein expression
responses to insulin, whereas age (Nur77: r2 = 0.22; NOR1: r2 = 0.25) and
BMI (Nur77: r2 = 0.22; NOR1: r2 = 0.42) showed inverse correlations, corrob-
orating preclinical data. In the intervention cohort, exercise improved Nur77
protein expression in response to insulin (PRE: 1.2  0.3%, POST: 6.2 
1.5%). Also, insulin treatment of primary human skeletal muscle cells increased
Nur77 and NOR1 protein. These findings highlight the multifactorial nature of
insulin resistance in human obesity and T2DM. Understanding the regulation
of Nur77 and NOR1 in skeletal muscle and other insulin-sensitive tissues will
create opportunities to advance therapies for T2DM.
Introduction
Gene microarray studies in the past decade have brought
about numerous putative therapeutic targets, especially
related to obesity and type 2 diabetes (T2DM). In skeletal
muscle, orphan nuclear receptors represent a group of tar-
gets that have been consistently identified in these screens.
In human skeletal muscle, two members of the orphan
nuclear receptor family, Nur77 and NOR1 (also known as
NR4A1 and NR4A3, respectively), received particular atten-
tion due to acute gene inductions in response to insulin
(Wu et al. 2007) and aerobic exercise (Mahoney and
Tarnopolsky 2005; Mahoney et al. 2005). Nur77 and
NOR1 control important pathways dysregulated in insulin
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resistance, like glucose (Kanzleiter et al. 2009, 2010) and
lipid metabolism (Maxwell et al. 2005; Chao et al. 2009,
2012), and are therefore promising targets for developing
therapeutics for chronic diseases, including obesity and
T2DM. Encouraging evidence from preclinical mouse
models show Nur77 and NOR1 overexpression increases
glucose uptake (Kanzleiter et al. 2009) and fat oxidation
(Chao et al. 2012). In agreement, mouse knockout models
display impaired insulin signaling, ectopic fat accumula-
tion, and increased susceptibility to diet-induced obesity
(Chao et al. 2009). Furthermore, Nur77 is reduced in the
skeletal muscle of murine models of insulin resistance (Pei
et al. 2006; Fu et al. 2007; Lessard et al. 2009) along with
obese humans (Kanzleiter et al. 2010). Additionally, a
defining characteristic in insulin resistance and T2DM is
the dysregulation of skeletal muscle genes and proteins in
response to insulin stimulation. Both Nur77 and NOR1
gene and protein expression are acutely induced by insulin
(Rome et al. 2003; Fu et al. 2007; Wu et al. 2007; Coletta
et al. 2008; Kanzleiter et al. 2010) in healthy skeletal mus-
cle. However, the acute response of Nur77 and NOR1 gene
and protein expression in response to insulin has not been
characterized in the context of obesity, insulin resistance or
T2DM.
Intensive lifestyle intervention, such as aerobic exercise
training, is a well-documented countermeasure to obesity,
insulin resistance, and T2DM. Chronic aerobic exercise
imparts robust benefits on insulin sensitivity, along with
glucose and lipid metabolism (O’Leary et al. 2006; Solo-
mon et al. 2008; Haus et al. 2009, 2010, 2011; Wang et al.
2009). These exercise-mediated metabolic improvements
are driven by chronic adaptations in skeletal muscle, for
example, skeletal muscle gene and protein responses to
insulin stimulation (Borghouts and Keizer 2000; Perry
et al. 2010). It was recently suggested that these skeletal
muscle responses may be regulated by NOR1 (Pearen and
Muscat 2018). Indeed, aerobic exercise acutely increases
both Nur77 and NOR1 (Mahoney et al. 2005) in healthy
individuals. Furthermore, evidence from skeletal muscle
cell culture (Maxwell et al. 2005), preclinical models
(Pearen et al. 2008; Kawasaki et al. 2009; Lessard et al.
2011) and humans (Mahoney et al. 2005; Lewis et al.
2010) demonstrate that aerobic exercise (or an exercise
effector in cell culture, ß-adrenergic stimulation) increases
Nur77 and NOR1 gene and protein expression. Despite
this evidence, well-designed metabolic studies investigat-
ing Nur77 and NOR1 gene and protein expression in
skeletal muscle have failed to demonstrate effect in the
context of obesity, insulin resistance and T2DM, or
following chronic adaptations to therapeutic lifestyle
interventions.
The purpose of this study was twofold. First, we sought
to characterize Nur77 and NOR1 protein expression in
response to insulin stimulation in human skeletal muscle.
We hypothesized that individuals with obesity or T2DM
would have reduced skeletal muscle Nur77 and NOR1
gene and protein expression in response to insulin stimu-
lation, related to the subject’s degree of insulin resistance.
Second, we examined the effect of an intensive lifestyle
intervention, involving aerobic exercise training and diet-
ary control, on skeletal muscle Nur77 and NOR1 gene
and protein expression. We hypothesized that aerobic
exercise training would normalize basal Nur77 and NOR1
gene and protein expression while improving the Nur77
and NOR1 protein response to insulin stimulation. We
expected these changes would be related to improvements
in insulin sensitivity. Finally, we utilized primary human
skeletal muscle cell cultures to examine the effects of iso-
lated insulin treatment on Nur77 and NOR1 protein




This study employed both cross-sectional and longitudinal
study designs. The cross-sectional investigation included
the study of 12 obese (OB) and 10 age- and BMI-matched
newly diagnosed insulin na€ıve T2DMs, along with 14
younger lean healthy controls (LHC). The LHC group
serves as a model of ideal skeletal muscle health and pro-
vides a reference group for comparison with the OB and
T2DM participants. Comprehensive metabolic characteri-
zation included an oral glucose tolerance test (OGTT),
hyperinsulinemic-euglycemic clamp and skeletal muscle
biopsy, at basal and insulin-stimulated conditions of the
clamp. A subsection of participants from the cross-sec-
tional cohort (12 OB and 6 T2DM) underwent an intensive
lifestyle intervention involving aerobic exercise training.
Metabolic characterization was repeated after completion
of the intervention. Skeletal muscle tissue samples were
probed for Nur77 and NOR1 gene and protein expression,
and skeletal muscle metabolic regulatory proteins. Subject
characteristics and metabolic data from a cohort of these
participants was previously published, however, this is the
first reporting of Nur77 and NOR1 in these participants
(Solomon et al. 2010; Williamson et al. 2015; Mahmoud
et al. 2016). Finally, primary human skeletal muscle myo-
blasts were differentiated into myotubes and used for
mechanistic validation of target proteins.
Subjects
Participants were recruited from the Cleveland, OH, and
Chicago, IL, metropolitan areas. All subjects were screened
2019 | Vol. 7 | Iss. 6 | e14042
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via health history, medical exam, resting EKG, and fasting
blood chemistry in the Clinical Research Centers of Metro-
Health Medical Center, the Cleveland Clinic, and the
University of Illinois at Chicago. Individuals were excluded
if they used nicotine, experienced > 2 kg weight change
within the previous 6 months, or had evidence of hemato-
logical, renal, hepatic, or cardiovascular disease. Body
composition was measured by dual-energy X-ray absorp-
tiometry (model iDXA; Lunar, Madison, WI). Glucose tol-
erance was characterized by a 75 g OGTT following a
standard 10- to 12-hour fasting period; LHCs were
excluded with a 2-h OGTT glucose > 140 mg/dL, whereas
OB were excluded with a 2-h OGTT glucose > 200 mg/
dL according to American Diabetes Association clinical
practice standards. All studies were approved by the
Institutional Review Boards of MetroHealth Medical Cen-
ter, the Cleveland Clinic and the University of Illinois at
Chicago and performed in accordance with the Declara-
tion of Helsinki. Written informed consent was obtained
from all research participants prior to initiating study
procedures.
Metabolic control procedures
For 3 days prior to metabolic testing, subjects were coun-
seled to eat a balanced diet that contained at least 200 g
of carbohydrate daily to stabilize muscle and liver glyco-
gen stores (Solomon et al. 2009). Subjects also provided a
3-day dietary recall, recording the time, volume, and con-
tent of food consumed. Subjects were asked to refrain
from consuming foods and beverages that contained caf-
feine 24 h prior to testing, and from consuming alcoholic
beverages 48 h prior to testing. Additionally, subjects
were instructed to refrain from physical activity outside
of their normal activities of daily living for 48 hours prior
to metabolic testing. The evening preceding metabolic
tests, subjects were provided a balanced meal containing
55% carbohydrate, 35% fat, and 10% protein. After the
meal, subjects fasted overnight for 10–12 h. All partici-
pants were asked to withhold medications known to affect
exercise performance and insulin sensitivity the evening
prior to metabolic testing. This approach has been used
successfully to control for the influence of diet and physi-
cal activity in the study of insulin sensitivity and metabo-
lism (Haus et al. 2010, 2011; Kelly et al. 2012).
Assessment of insulin sensitivity and
substrate utilization
Whole-body insulin sensitivity was assessed using the
hyperinsulinemic (40 mU/m2/min)-euglycemic (5 mmol/
L) clamp procedure, performed as previously detailed
(Solomon et al. 2010; Williamson et al. 2015). Blood
glucose was measured every 5 min via YSI glucose-lactate
analyzer (YSI 2300; STAT Plus, Yellow Springs, OH) and
was clamped at 90 mg/dL by variable glucose infusion
(20% dextrose). Glucose disposal rates (GDR; mg/kg/
min) were calculated as the mean rate obtained during
steady-state insulin-stimulated conditions and whole-body
insulin sensitivity is reported as “M/I” (mg/kg/min/
lU.mL) and calculated from GDR normalized to the
steady-state insulin concentration during 90–120 min of
the clamp procedure. Indirect calorimetry was performed
prior to starting the clamp (basal, postabsorptive
metabolism) and during 90–120 min (insulin-stimulated
metabolism) of the clamp procedure. Expired air was
continuously sampled for a minimum of 20 min with an
automated system (Viasys HealthCare, Yorba Linda, CA;
Parvo Medics, Sandy, UT) in a semidarkened, ther-
moneutral (22  1°C) environment under a ventilated
hood with subjects laying supine. The equations of Weir
(1949) and Frayn (1983) were used to calculate energy
expenditure (BMR) and substrate oxidation rates (carbo-
hydrate oxidation, COX; fat oxidation, FOX). In addition,
overnight, timed urinary nitrogen excretion measurements
(Roche Modular Diagnostics, Indianapolis, IN) were also
made to correct for protein metabolism (Frayn 1983).
Nonoxidative glucose metabolism was calculated as GDR
minus insulin-stimulated carbohydrate oxidation. Pre and
postintervention metabolic flexibility was calculated as the
response of postabsorptive substrate metabolism to hyper-
insulinemic conditions, for example, insulin-stimulated
respiratory exchange ratio (RER) minus postabsorptive
RER (Solomon et al. 2009).
Skeletal muscle biopsy
Skeletal muscle biopsies (~200 mg) of the vastus lateralis
were obtained under local anesthesia (Lidocaine HCl
1%), (Trappe et al. 2013) using a 5 mm Bergstrom needle
with suction (Bergstrom 1975; Evans et al. 1982) during
the baseline (0 min) and insulin-stimulated (120 min)
periods of the hyperinsulinemic-euglycemic clamp proce-
dure (Williamson et al. 2015; Mahmoud et al. 2016).
Muscle tissue was blotted, trimmed of adipose and con-
nective tissue, immediately flash frozen in liquid nitrogen,
and subsequently stored at 80°C for later analysis. An
aliquot of muscle tissue (~20 mg) was placed into RNA-
Later (AMBION, Inc., Austin, TX) and stored at -20°C
until processing for extraction of total RNA.
Aerobic exercise training intervention
A subcohort of 18 participants (OB, n = 12; T2DM,
n = 6) were enrolled in a 12-week intensive lifestyle inter-
vention. Insulin sensitivity, aerobic fitness, glucose and
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lipid metabolism, and skeletal muscle gene, and protein
targets were measured before and after the intervention.
Stringent control procedures included a 2-day screening
procedure, 3-day inpatient stays for pre and posttesting
procedures, 12 weeks of fully supervised exercise, and a
full diet provision (isocaloric) during the intervention
period; all of which have been detailed previously (Solo-
mon et al. 2010). The exercise intervention provided
60 minutes of aerobic exercise 5 days/wk for 12 weeks
(treadmill walking and cycle ergometry) at 70% VO2max
(85% of the HRmax). A 5-min warm up and cool down
were performed during each exercise bout and are
included within the 60-min total. Subjects also performed
stretching exercises for the quadriceps, hamstrings, and
gastrocnemius before and after each session. A maximal
exercise test was used to assess cardiovascular fitness as
well as to adjust exercise intensities throughout the 12-
week intervention to maintain training intensity at 70%
VO2max. To avoid acute effects of exercise on insulin
sensitivity, exercise testing was performed ~48 h before
metabolic testing and sample collections.
Maximal oxygen consumption
Maximal oxygen consumption (VO2max) and maximum
heart rate (HRmax) were determined from an incremental
treadmill test using a modified Bruce protocol. Expired air
was continuously sampled online with the use of an auto-
mated system (Jaeger Oxycon Pro; Viasys, Yorba Linda,
CA). Each test was conducted by an exercise physiologist.
The test was considered successful if ≥ 3 of the following
criteria were reached: plateau in oxygen consumption with
increasing workload, volitional fatigue, heart rate ≤ 10
beats/min of the age-predicted maximum, or a respiratory
exchange ratio > 1.10 (Solomon et al. 2010).
Analytical assessments
For immunoblotting, approximately 10–15 mg (wet
weight) of frozen muscle tissue was homogenized by cera-
mic beads (lysing matrix D; FastPrep-24 homogenizer,
MP Biomedicals, Santa Ana, CA) in 20 volumes of ice-cold
lysis buffer (Cell Signaling Technology, Beverly, MA) sup-
plemented with a protease and phosphatase inhibitor cock-
tail (MS-SAFE, Sigma Aldrich, St Louis MO). Total protein
concentration was determined via BCA Protein Assay
(Pierce Biotechnology, Rockford, IL) and proteins were
separated via 10% SDS-PAGE and transferred to either
PVDF or nitrocellulose membranes (Mey et al. 2017;
Mulya et al. 2017). Blotting conditions were optimized
individually for each protein of interest using the antibod-
ies as follows: Nur77 (sc-7014, Santa Cruz Biotechnologies,
Dallas, TX; ab109180, Abcam, Cambridge, MA), NOR1
(sc-393903, Santa Cruz Biotechnologies; ab56340, Abcam,),
ß-Actin (sc-130656, Santa Cruz Biotechnologies), and
GAPDH (2118S; Cell Signaling Technology, Beverly, MA).
Secondary antibodies were selected for the appropriate spe-
cies and imaging procedures. Chemiluminescence (GE
Healthcare, Piscataway, New Jersey) or near-infrared fluo-
rescence imaging (Odyssey Clx, LI-COR Biosciences, Lin-
coln, NE) was used for protein visualization. GAPDH and
ß-Actin were used as loading controls.
For gene expression, skeletal muscle total RNA was
extracted using the RNeasy Fibrous Tissue Mini Kit
(Qiagen, Germantown, MD) with modifications for extrac-
tion from skeletal muscle stored in RNALater. RNA con-
centration and quality were determined by NanoDrop
spectrophotometer (Thermo Scientific, Wilmington, Dela-
ware). Total RNA (1 lg) was reverse transcribed to cDNA
(Clontech, Mountain View, CA) and target genes were ana-
lyzed using quantitative real-time PCR via Brilliant SYBR
Green DNA intercalation (Agilent, Santa Clara, CA).
Human GAPDH primer pairs were purchased from BIO-
MOL International (Plymouth Meeting, PA) and all other
primer pairs were designed and purchased through Inte-
grated DNA Technologies (Coralville, IA). For human
NOR1, previous research defined four gene variants that
encode three distinct protein isoforms (A, B, C) (Ohkura
et al. 1998). The individual physiological functions of these
isoforms remain unknown in human skeletal muscle, and
thus all isoforms were examined via individualized primers
for each isoform. Primer sequences and accession number
details are outlined in Table 1. GAPDH was used for
normalization as a housekeeping gene and gene expression
was determined using the 2DCT relative quantification
method.
Cell culture validation study
Cell culture studies have previously shown that a putative
mechanism by which acute exercise induces Nur77 and
NOR1 gene and protein expression is through ß-adrener-
gic stimulation, which can be recapitulated through iso-
prenaline treatment (Pearen et al. 2006, 2008; Myers et al.
2009). Whole-body insulin stimulation has also been
shown to induce a ß-adrenergic response (Creager et al.
1985), thus leaving the independent effects of insulin on
Nur77 and NOR1 unknown in human skeletal muscle. To
unmask the direct effects of insulin on Nur77 and NOR1
protein expression without ß-adrenergic stimulation, we
utilized primary human skeletal muscle cells in culture.
Skeletal muscle myoblasts (Lonza, Walkersville, MD) were
isolated from a young healthy donor, seeded into stan-
dard 100 mm dishes at a density of 3500 cells/cm2 and
maintained in skeletal muscle growth medium (SKGM;
Lonza) supplemented with 0.1% human epidermal
2019 | Vol. 7 | Iss. 6 | e14042
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growth factor, 1% fetuin, 1% bovine serum albumin,
0.1% dexamethasone, 1% insulin and 0.1% gentamycin/
amphotericin B. Cells were kept in a humid atmosphere
at 37°C and 5% CO2 during all stages of the experimental
process. When cells reached ~90% confluence, growth
medium was replaced with differentiation medium
(DMEM-F12 supplemented with 2% horse serum and 1%
antibiotic). Differentiation medium was refreshed every
other day for 3 to 5 days until multinucleated myotubes
were observed throughout the culture. Following differen-
tiation, cells were returned to SKGM supplemented with
insulin to 300 pM for 0, 30, and 180 min. We selected
300 pM insulin because it mimics postprandial hyperin-
sulinemia and is consistent with concentrations observed
during the hyperinsulinemic-euglycemic clamp procedure.
However, Fu et al. (Fu et al. 2007) showed that insulin
(100 nmol/L) treatment maximally induced NR4A3
mRNA at 2 h. After the completion of experimental con-
ditions, cells were harvested by the cell scraping method
into ice cold cell lysis buffer (#9803S, Cell Signaling) and
prepared for immunoblotting as described above.
Statistical analysis
Statistical analyses were performed using PRISM (Graph-
Pad Software, La Jolla, CA). Data were tested for normality
using the Shapiro–Wilk normality test. Datasets that were
not normally distributed were log10 transformed for para-
metric analyses. A one-way repeated measures ANOVA
was used to test differences between groups (LHC vs. OB
vs. T2DM). Paired t-tests were used for comparison of
gene and protein expression before and after the exercise
training intervention. Pearson’s correlation was used to
investigate relationships among gene and protein targets
and markers of metabolic health. Data are expressed as
mean  SEM. Statistical significance was accepted at
P < 0.05.
Results
Baseline characteristics of the cross-
sectional cohort
Baseline characteristics of the cross-sectional cohort are
presented in Table 2. By design, the OB and T2DM sub-
jects were older, weighed more, maintained a higher BMI
and were more insulin resistant compared to the LHC
participants. However, age and BMI were matched
between OB and T2DM subjects.
Nur77 and NOR1 protein response to insulin
in the cross-sectional cohort
Skeletal muscle Nur77 and NOR1 protein expression
increased in response to insulin stimulation in LHC
(Nur77: 8.7  3.2-fold, P < 0.01; NOR1: 3.6  1.1-fold,
P < 0.05), but remained unchanged in OB (Nur77:
1.0  0.3-fold, P > 0.05; NOR1: 1.0  0.1-fold, P > 0.05)
and T2DM (Nur77: 1.1  0.1-fold, P > 0.05; NOR1:
1.0  0.1-fold, P > 0.05) (Fig. 1A–D). Correlational analy-
sis of all participants showed individuals had similar Nur77
and NOR1 inductions with insulin stimulation (r2 = 0.34,
P < 0.001, Fig. 1E). Correlational analysis was also used to
investigate potential relationships between the Nur77 and
NOR1 response to insulin and markers of obesity and
metabolic health. The Nur77 response to insulin was inver-
sely correlated with age (r2 = 0.22, P < 0.01, Fig. 2A) and
BMI (r2 = 0.21, P < 0.01, Fig. 2B), but was positively cor-
related with clamp-derived insulin sensitivity (M/I; r2 =
0.14, P < 0.05, Fig. 2C). Similarly, the NOR1 response to
insulin was inversely correlated with age (r2 = 0.25, P < 0.01,
Fig. 3A), BMI (r2 = 0.42, P < 0.01, Fig. 3B), FPG (r2 = 0.28
P < 0.01, Fig. 2D) and HbA1c (r
2 = 0.12, P < 0.05, Fig. 2E),
but was positively correlated with clamp-derived insulin
sensitivity (M/I; r2 = 0.12, P < 0.05, Fig. 2C).
Table 1. Primers.
Gene Forward Primer (50 – 30) Reverse Primer (50-30) Accession #
Nur77 ACT GGA TTG ACA GTA TCC TGG C CCA ACA GAC GTG ACA GGC A NM_002135.3
NOR1-A ATG AGG TGG GAG AAA GCA ACC ACA TGG CCA AGG GAG AGA GTT GAC ATT NM_173198
NOR1-B TTG GAA ATG TGG ATA TGC CCT GCG AAG GTC CAT GGT CAG CTT GGT GTA NM_173200
NOR1-C GAT TCC TGG TGG TTG TGC CAA TGA TGA GGC TCA CCC AGA TGG TTT GAA NM_173199
PGC1a CAA GCC AAA CCA ACA ACT TTA TCT CT CAC ACT TAA GGT GCG TTC AAT AGT C NM_013261
PDK4 TGA GAC TCG CCA ACA TTC TG CCA AAT CCA TCA GGC TCT GT NM_002612.3
Lipin1a TAA TGC CAG TTA CGA CGC TG CAT TCC TCG ATT GAC CCT GT NM_145693.1
GAPDH TGA TGA CAT CAA GAA GGT GGT GAA G TCC TTG GAG GCC ATG TGG GCC AT NM_002046
Nur77, orphan nuclear receptor NR4A1; NOR1-A, orphan nuclear receptor NR4A3 isoform A; NOR1-B, orphan nuclear receptor NR4A3 isoform
B; NOR1-C, orphan nuclear receptor NR4A3 isoform C; PGC1a, peroxisome proliferator-activated receptor (PPAR) c coactivator-1a; PDK4, pyru-
vate dehydrogenase kinase-4; GAPDH, glyceraldehyde-3-phosphate dehydrogenase.
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Physiologic and metabolic effects of the
lifestyle intervention
Data describing the effects of the exercise intervention are
detailed in Table 3. As a result of the intervention subjects
reduced bodyweight (D 8.5  1.2 kg, P < 0.0001) and
BMI (D 3.0  0.4 kg/m2, P < 0.0001) while maintaining
FFM (D 0.2  0.8 kg, P > 0.05) and improving aerobic
capacity (D 6.6  0.9 mL/kg/min, P < 0.0001) and clamp-
derived GDR (D 1.6  0.4 mg/kg/min, P < 0.0001). Con-
currently, skeletal muscle glycogen content increased at
basal (D 10.6  8.8 mmol/kg wet wt.) and insulin-stimu-
lated conditions (D 44.4  6.8 mmol/kg wet wt.).
Nur77 and NOR1 gene and protein
expression with chronic aerobic exercise
training
Skeletal muscle gene expression for Nur77 and three iso-
forms of NOR1 (Isoform A, B, C) were analyzed at basal
and under insulin-stimulated conditions, before and after
the aerobic exercise training intervention (Fig. 4A–D).
Table 2. Subject characteristics of the cross-sectional cohort.
LHC OB T2DM
N (sex) 14 (6 m, 8f) 12 (7 m, 5f) 10 (5 m, 5f)
Age (yrs.) 31  1 66  11 62  31
Weight (kg) 64  3 100  41 94  51
BMI (kg/m2) 22  1 35  11 33  11
FPG (mg/dL) 91  1 101  21 125  91,2
GDR (“M,” mg/kg/min) 6.4  0.5 2.5  0.31 2.7  0.41
Insulin Sensitivity (“M/I”)
(mg/kg/min/lU.mL)
0.115  0.010 0.027  0.0041 0.025  0.0051
Data represent mean  SEM.
LHC, lean healthy control subjects; OB, obese individuals with insulin resistance; T2DM, individuals with Type 2 Diabetes Mellitus; BMI, Body
Mass Index; FPG, fasting plasma glucose; GDR, glucose disposal rate as calculated from the hyperinsulinemic-euglycemic clamp; M/I, clamp-
derived glucose disposal rate normalized to prevailing insulin concentration; 1different from LHC; 2different from OB; one-way ANOVA with
Bonferroni post hoc test P < 0.05.
Figure 1. Skeletal muscle Nur77 and NOR1 protein expression. (A) Representative Western blot image for Nur77. (B) Nur77 is robustly induced
by insulin stimulation in LHC, whereas this effect is blunted in OB and T2DM. (C) Representative Western blot image of NOR1. (D) NOR1 is
robustly induced by insulin stimulation in LHC, whereas this effect is blunted in OB and T2DM. (E) Correlation between Nur77 and NOR1
protein response to insulin. LHC, lean healthy control subjects; OB, obese individuals with insulin resistance; T2DM, individuals with type 2
diabetes mellitus; B, Basal, t = 0 min; I, Hyperinsulinemia, t = 120 min. *, significant difference from LHC; one-way ANOVA with Bonferroni
post hoc P < 0.01; †, significant difference from LHC; one-way ANOVA with Bonferroni post hoc P < 0.05. Data presented has been log10
transformed for normality.
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Nur77 gene expression remained unchanged in response to
insulin following the exercise intervention (Fig. 4A). All
three NOR1 isoforms showed an attenuated response to
insulin following exercise training (Fig. 4B–D). Known
skeletal muscle regulatory targets (Wang and Muscat 2013)
(PPAR-y coactivator-1a, PGC1a; pyruvate dehydrogenase
kinase-4, PDK4; lipin1a; Fig. 4E–G) were also analyzed at
basal and under insulin-stimulated conditions, before and
after the exercise intervention. The intervention did not
have any significant effect on skeletal muscle PGC1a,
PKD4, or lipin1a gene expression in response to insulin.
To determine whether the Nur77 and NOR1 gene
responses translated into functional proteins, we analyzed
skeletal muscle protein expression before and after the
Figure 2. Baseline Nur77 correlations. The increase in Nur77 protein expression in response to insulin stimulation (“response to insulin”)
negatively correlated with age (A) and BMI (B) and was positively associated with insulin sensitivity (“M/I” (mg/kg/min/lU.mL), C). A log10
transformation was used to normalize the Nur77 data.
Figure 3. Baseline NOR1 correlations. The increase in NOR1 protein expression in response to insulin stimulation (“response to insulin”) was
negatively correlated with age (A) and BMI (B) and was positively associated with insulin sensitivity (“M/I” (mg/kg/min/lU.mL), (C) and improved
glucose control (fasting plasma glucose, D; HbA1c, E). A log10 transformation was used to normalize the Nur77 data.
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lifestyle intervention. Chronic aerobic exercise training
modestly increased Nur77 protein expression in response
to insulin stimulation (Fig. 5A; PRE: 1.2  0.3%, POST:
6.2  1.5%, P = 0.024), whereas NOR1 showed a similar
trend, but remained statistically unaffected (Fig. 5B). The
changes observed in Nur77 protein response to insulin after
exercise training were associated with changes in NOR1
protein response to insulin after exercise training (Fig. 5C),
in agreement with our cross-sectional characterization.
Cell culture validation study
We conducted a cell culture validation study to verify the
normal physiologic response to insulin on Nur77 and
NOR1 protein expression in human skeletal muscle myo-
tubes. In response to 300 pM insulin, Nur77 protein
expression remained unchanged at 30 minutes, but was
significantly increased at 180 min (Fig. 6A; 183  12.6%
compared to baseline, 1-way ANOVA, P = 0.002; Bonfer-
roni’s Multiple Comparison post hoc test, P < 0.05.)
NOR1 protein expression displayed a similar trend, but
with lesser magnitude did not reach statistical significance
at 180 minutes (Fig. 6B, 131  6.3% compared to base-
line, 1-way ANOVA, P = 0.070). These results suggest
insulin stimulates Nur77 and NOR1 protein expression in
human skeletal muscle cells independent of the ß-adre-
nergic effect of insulin.
Discussion
To our knowledge, these are the first data to show that
skeletal muscle Nur77 and NOR1 protein expression is
blunted in response to insulin in obesity and overt T2DM,
and that aerobic exercise training improves this response.
Since insulin is an important physiological regulator of glu-
cose and fatty acid metabolism, we focused our investiga-
tion on the changes in response to insulin stimulation
during the hyperinsulinemic-euglycemic clamp. Glucose
and lipid metabolism are known to be dysregulated in obe-
sity, insulin resistance, and T2DM. Therefore, understand-
ing the major control points underlining these metabolic
derangements may lead to the development of novel thera-
pies for the prevention and treatment of obesity and
T2DM. Previous research from cell culture and animal
models suggest an important role for both Nur77 and
NOR1 in glucose and lipid metabolism (4-8). While pre-
clinical and human studies have described defects in Nur77
and NOR1 in obesity (4; 9-11), the data herein deepen our
understanding of how skeletal muscle Nur77 and NOR1
may function across a range of human phenotypes: LHC,
to OB and T2DM. Furthermore, the associations between
the Nur77 and NOR1 protein response to insulin, with
multiple measures of metabolic function, provides addi-
tional incentive to investigate Nur77 and NOR1 in the con-
text of insulin resistance and T2DM.
An important finding from the cross-sectional analysis
was the remarkable blunting of the Nur77 and NOR1
response to insulin, which occurred to a similar extent in
both the OB and T2DM groups compared to LHC. This
suggests dysregulated Nur77 and NOR1 signaling may
present early in the natural history of diabetes and likely
reaches a conceptual “floor” in early insulin resistance.
Given this early-onset blunting, Nur77 and NOR1 present
an intriguing therapeutic target to prevent the progression
from obesity (a prediabetic, insulin resistance state) to
overt T2DM. Furthermore, we conducted a subgroup
analysis of the OB participants, a group that exhibits the
most heterogeneity related to metabolic health across the
spectrum, spanning healthy physiology to overt T2DM.
Table 3. Metabolic characteristics of the lifestyle intervention
cohort.
PRE POST
N 18 (11 m, 7f) 18
Age (yrs.) 66  1 –
Weight (kg) 97.9  3.7 89.5  3.11
BMI (kg/m2) 34.5  1.0 31.5  0.91
Fat Free Mass (kg) 56.3  2.7 56.1  2.7
VO2max (mL/kg/min) 21.6  0.8 28.1  1.51
FPG (mg/dL) 109  4 101  31
GDR (mg/kg/min) 2.6  0.3 4.2  0.31
M/I (mg/kg/min/lU.mL) 0.024  0.003 0.041  0.0051
RQ (AU) 0.84  0.01 0.83  0.01
Metabolic Flexibility (AU) 0.03  0.01 0.06  0.011
Fat OxidationBasal
(mg/kg FFM/min)
1.11  0.10 1.10  0.12
Fat OxidationInsulin
(mg/kg FFM/min)
0.76  0.08 0.57  0.071
COX (mg/kg FFM/min) 2.06  0.24 1.95  0.26
NOGD (mg/kg FFM/min) 1.7  0.6 4.1  0.61
Glycogen ContentBasal
(mmol/kg wet wt.)
88  10 105  51
Glycogen ContentInsulin
(mmol/kg wet wt.)
102  9 155  81
Data represent mean  SEM.
The OB and T2DM subjects from the cross-sectional analysis have
been combined into PRE and POST, which represents data collection
points before and after the intensive lifestyle intervention; BMI,
Body Mass Index; GDR, Glucose Disposal Rate as calculated from
the hyperinsulinemic-euglycemic clamp; VO2max, maximal oxygen
consumption during maximal aerobic exercise testing; COX, Carbo-
hydrate Oxidation; NOGD, Nonoxidative Glucose Disposal; BMR,
Basal Metabolic Rate; RQ, Respiratory Quotient; FPG, Fasting Plasma
Glucose; M/I, GDR normalized to the prevailing insulin concentra-
tion during the final 90–120 min of the hyperinsulinemic-euglyce-
mic clamp (mg/kg/min/lU.mL); 1significant effect of the 12-week
intensive lifestyle intervention; paired sample t-test, P < 0.05.
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This analysis revealed that poorer glucose control (fasting
plasma glucose) was associated with reduced Nur77
(r2 = 0.45, P = 0.017, n = 12) and NOR1 (r2 = 0.40,
P = 0.028, n = 12) response to insulin. In agreement with
data from the full cohort, the relationship between insulin
sensitivity (M/I) and the Nur77 and NOR1 response to
insulin, data from the OB group suggest that metabolic
health and the Nur77 and NOR1 protein response to
insulin are altered in unison across the glucose tolerance
continuum and follow the natural history of diabetes.
Future research should investigate if normalizing the
Nur77 and NOR1 response to insulin in obese, insulin-
resistant individuals (prediabetic) can maintain or
improve insulin sensitivity and prevent the progression
toward overt T2DM.
While we did not examine the specific mechanisms
behind these observations, current preclinical literature in
this area may provide insight into why obesity and insulin
resistance attenuate orphan nuclear receptor responses to
insulin. For example, Nur77 and NOR1 are transcrip-
tional regulators of glucose metabolism and downstream
effectors of b-adrenergic receptor signaling (Coletta et al.
2008). Thus, we speculate that the early-onset of insulin
resistance and impaired metabolic flexibility is directly
linked to Nur77 and NOR1 down regulation, which sub-
sequently exacerbates impaired metabolic flexibility.
In addition to the cross-sectional comparison between
LHC, OB, and T2DM, we performed a therapeutic
lifestyle intervention in OB and T2DM participants
involving aerobic exercise training. Our selection of this
Figure 4. Skeletal muscle gene expression before and after exercise training. (A) Nur77 gene expression in response to insulin stimulation was
unchanged after exercise training. (B–D) The NOR1 Isoform A, B, and C response to insulin was significantly reduced after exercise training. (E–
G) PGC1a, PKD4, and lipin1a gene expression in response to insulin stimulation was unchanged after exercise training. *, P < 0.05.
Figure 5. Nur77 and NOR1 protein response to insulin before and after exercise training. (A) The Nur77 protein expression in response to
insulin modestly improved from PRE to POST exercise training (PRE: 1.2  0.3%, POST: +6.2  1.5%, P = 0.024), whereas the NOR1
response to insulin remained unchanged (B). With aerobic exercise training, changes in the Nur77 response to insulin were associated with
changes in the NOR1 response to insulin (C).
ª 2019 The Authors. Physiological Reports published by Wiley Periodicals, Inc. on behalf of
The Physiological Society and the American Physiological Society.
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intervention was twofold: aerobic exercise training is a
well-documented countermeasure to obesity and T2DM
that confers benefit through skeletal muscle adaptations,
and aerobic exercise training has been previously shown
to stimulate Nur77 and NOR1 gene expression (Chao
et al. 2009; Mey et al. 2017). We observed a significant
effect of exercise training on skeletal muscle gene expres-
sion of NOR1 isoforms A, B, and C, whereas Nur77 gene
expression was unchanged after exercise training. These
gene expression changes were not mirrored in our analy-
sis of Nur77 and NOR1 protein expression, as Nur77
protein expression increased with insulin stimulation only
after the aerobic exercise training intervention. Our basal
gene expression data corroborate previous findings from
microarray analysis in combination with the hyperinsu-
linemic-euglycemic clamp (Rome et al. 2003; Wu et al.
2007; Coletta et al. 2008; Kanzleiter et al. 2010). In con-
trast to our hypothesis, we observed a marked attenuation
in insulin-stimulated NOR1 isoform A, B, and C gene
expression. We generated our hypothesis based on cell
culture, murine, and human microarray data evidencing
the stimulatory effect of exercise on Nur77 and NOR1
gene expression. However, the prior human studies were
performed in untrained, healthy adults, and skeletal mus-
cle samples were obtained within 3 h of exercise (Maho-
ney and Schwartz 2005; Mahoney et al. 2005). It is
possible that the insulin-resistant skeletal muscle in OB
and T2DM subjects present with translational repression
of Nur77 and NOR1 (Rodriguez-Calvo et al. 2017). To
compensate for this inability to translate the gene
responses into functional protein, OB and T2DM skeletal
muscle may bolster Nur77 and NOR1 gene expressions in
response to insulin stimulation, without concomitant
increases in protein expression. The reductions observed
in NOR1 gene expression in response to insulin stimula-
tion may then represent a movement toward a healthier
phenotype, and is in line with our Nur77 and NOR1 pro-
tein observations. Still, there remains a clear deficiency in
Nur77 and NOR1 gene and protein regulation in
response to insulin in OB and T2DM, even after the
advent of a chronic aerobic exercise intervention. This
aligns with other research showing that individuals with
T2DM have epigenetic modifications that reduce Nur77
gene expression and inhibit insulin signaling (Chen et al.
2016). Still, this requires additional investigation and will
improve the understanding of Nur77 and NOR1 physiol-
ogy. Prior research utilizing acute aerobic exercise has
shown increases in basal Nur77 and NOR1 (Goode et al.
2016) protein expression. However, we did not observe
differences in basal expression of Nur77, NOR1 or the
putative transcriptional targets (PDK4, PGC1a, LIPIN1a)
after the exercise intervention, which is consistent with
others (Mahoney et al. 2005). This may have arisen
because our sample acquisition occurred > 48 h after the
final bout of exercise training, a timeline that represents a
critical control point for our metabolic measures, but pre-
vents the observation of an acute effect of aerobic exercise
on skeletal muscle Nur77 and NOR1. Whether the acute
stimulation of Nur77 and NOR1 skeletal muscle gene
expression observed by others in lean, healthy individuals
is blunted in obesity or T2DM remains to be elucidated.
Nevertheless, we observed modest increases in the Nur77
protein response to insulin after aerobic exercise training,
which indicates an improvement toward a lean, healthy
phenotype and mirrors the metabolic improvements in
response to insulin imparted by the lifestyle intervention
used in this study. This trend toward a lean, healthy phe-
notype without complete normalization is an understand-
able result, as the exercise participants were still older,
overweight, and insulin resistant compared to LHC.
Whether the Nur77 or NOR1 gene and protein response
to insulin can be fully normalized with continued exercise
Figure 6. Cell culture validation study. Human skeletal muscle cells were treated with 300 pM insulin for 0, 30, and 180 min. (A) Nur77
protein expression was unchanged at 30 minutes, but significantly increased at 180 min (one-way ANOVA, P = 0.0016). (B) NOR1 protein
expression showed a similar trend, but did not reach significance (1-way ANOVA, P = 0.0701). *, Bonferroni post hoc P < 0.05 compared to
baseline, Φ, P < 0.05 compared to 30 min.
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training remains to be determined, but represents a
promising area for future research, for example, pharma-
cologic targeting of orphan nuclear receptors.
Finally, we performed a validation study to examine
the independent effect of insulin stimulation in human
skeletal muscle cells. Prior research in rat and mouse
skeletal muscle has focused on Nur77 and NOR1 gene
expression, primarily in response to ß-adrenergic stimula-
tion utilizing isoprenaline (Pearen et al. 2006, 2008;
Myers et al. 2009). Furthermore, it has been documented
that in vivo insulin stimulation imparted by the hyperin-
sulinemic-euglycemic clamp procedure induces a ß-adre-
nergic response (Young et al. 2010). Therefore, we were
interested in investigating the Nur77 and NOR1 protein
expression in response to insulin stimulation utilizing a
human skeletal muscle cell culture model, which removes
the confounding ß-adrenergic response to insulin stimula-
tion observed in vivo. Our results indicate an indepen-
dent effect of insulin stimulation on Nur77 and NOR1
protein expression after 180 min of physiologic insulin
stimulation. Taken together with our in vivo human data,
the results are promising and suggest that Nur77 and
NOR1 may be partly responsible for the physiologic dif-
ferences in response to insulin stimulation observed in
OB and T2DM individuals.
Limitations
We utilized a lean, healthy control group as a measure of
optimal health to understand normal Nur77 and NOR1
physiology in response to insulin. By design, the control
group was younger, more fit and more insulin sensitive
than the OB and T2DM groups. Although differences in
age limits our ability to distinguish the primary driver of
the blunted Nur77 and NOR1 response to insulin in OB
and T2DM, the data do provide clear evidence of a devia-
tion from healthy physiology in our obese and diabetic
cohorts. Furthermore, we confirmed that the relationship
between both the Nur77 or NOR1 protein response to
insulin and insulin sensitivity (M/I), persists after control-
ling for age (Nur77: r2 = 0.22, adjusted r2 = 0.18, P =
0.015; NOR1: r2 = 0.65, adjusted r2 = 0.63, P < 0.0001).
Still, future research on the Nur77 and NOR1 response to
insulin stimulation should utilize an age-matched control
group to better assess the impact of obesity or T2DM per
se. These results are exciting given that the lifestyle inter-
vention in OB and T2DM increased the Nur77 response
to insulin, suggesting a return toward a healthy physio-
logical state. The lifestyle intervention involved aerobic
exercise training and nutritional caloric restriction which
elicited weight loss and improved insulin sensitivity.
Although we are unable to fully differentiate the indepen-
dent effects of these primary lifestyle factors (aerobic
fitness and weight loss), correlational analysis suggests
neither aerobic fitness nor weight loss is related to the
Nur77 or NOR1 protein response to insulin. Collectively,
these data show that a lifestyle intervention in OB and
T2DM initiates a return toward healthy skeletal muscle
physiology, which is mirrored by changes in skeletal mus-
cle Nur77 and NOR1. On a technical note, we were
forced to use two different primary antibodies and load-
ing controls in this study due to unforeseen problems
with our antibody supplier and detection method. Thus,
we displayed our protein expression data as fold change
to examine insulin responsiveness, which was the focus of
this investigation in any event.
Conclusion
The data provide evidence that Nur77 and NOR1 insulin
responsiveness is blunted in obesity and T2DM, and that
a lifestyle intervention involving aerobic exercise training
partially recovers this response. This research provides an
extension of current knowledge (Pearen and Muscat
2018), and provides incentive to investigate the therapeu-
tic potential of Nur77 and NOR1 for the treatment and
prevention of T2DM. Further mechanistic work to under-
stand the precise regulation of these signaling molecules
will help to achieve this therapeutic potential.
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